Speaker

Yi Yang

Director of Cell & Gene Therapy, Novartis AG

Yi Yang, Director of Cell & Gene Therapy at Novartis AG, is speaking at 2nd T-Cell Engager for Autoimmune Disease Summit (Boston, United States of America, 27–29 Oct 2026) in the session “Workshop B: Building Predictive Development Strategies for Autoimmune T-Cell Engagers, From Ex Vivo Models to Clinical Trial Execution, for Optimized Patient Outcomes”.

Conferences: 1
Keynotes: 0
Upcoming: 1

Upcoming appearances

2nd T-Cell Engager for Autoimmune Disease Summit
27–29 Oct 2026Boston, United States of America
- WorkshopWorkshop B: Building Predictive Development Strategies for Autoimmune T-Cell Engagers, From Ex Vivo Models to Clinical Trial Execution, for Optimized Patient Outcomes
- PanelPanel Discussion: Demonstrating Differentiation in a Crowded Autoimmune TCE Landscape While Navigating an Evolving Regulatory PathwayWith Patrick Baeuerle, Zhinan Xia, Mike Jones

More speakers at 2nd T-Cell Engager for Autoimmune Disease Summit

Giovanni Abbadessa
Chief Medical Officer, ModeX Therapeutics
Xingfeng Bao
Senior Vice President & Head of Research, GV20 Therapeutics LLC
Alexander Boches
Chief Business Officer, NovalGen
Elaine Chen
Senior Scientist, Translational Biology, Rondo Therapeutics
David de Graaf
Co-Founder, CEO & President, Reverb Therapeutics Inc.
Mauricio Garcia-Atance
Program Director, Hanson Wade

See all 18 speakers on the event page

This profile is built from conference programmes published on kongre.net. It has not been claimed or confirmed by Yi Yang, and it lists only the talks, sessions and presentations named in those programmes.

Is this you? Claim this profile — every request is read by a person before anything is linked.

To ask for a correction or for this profile to be removed, email [email protected].